Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
27.56
-1.07 (-3.74%)
Jul 31, 2026, 10:43 AM EDT - Market open
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $1.07 billion as of July 31, 2026. Its market cap has increased by 1,180.61% in one year.
Market Cap
1.07B
Enterprise Value
872.31M
1-Year Change
1,180.61%
Ranking
Category
Stock Price
$27.56
ChartMarket Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $1.07B, an increase of 102.63%. That is a compound annual growth rate of 32.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 1.04B | 87.82% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 1.12B |
| MeiraGTx Holdings | 1.09B |
| Vor Biopharma | 1.08B |
| Cullinan Therapeutics | 1.07B |
| Seaport Therapeutics | 1.07B |
| Inventiva | 1.06B |
| Alpha Tau Medical | 1.04B |
| Lexicon Pharmaceuticals | 1.04B |